Metopocor

Metoprolol Tartrate, the active ingredient in Metopocor, is a beta blocker presented as an intravenous solution for intravenous use. It treats hypertension, angina pectoris, acute myocardial infarction and cardiac arrhythmias in adult patients.

GNH USA supplies Metopocor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metopocor, a selective β1‑adrenergic blocker, is used in several cardiovascular conditions.

- Hypertension: lowers blood pressure by reducing heart rate and myocardial contractility. - Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand. - Acute myocardial infarction: improves survival by reducing cardiac workload. - Cardiac arrhythmias: helps control heart rhythm by slowing conduction through the atrioventricular node.

Common side effects are generally mild and may resolve with continued therapy.

Common Side Effects: - Fatigue - Dizziness or light‑headedness - Bradycardia - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with reactive airway disease - Allergic reactions (rash, angioedema, anaphylaxis) - Depression or mood changes - Cardiogenic shock in susceptible individuals

Before initiating therapy, consider the following precautions. - Dose adjustment in renal impairment: reduce dose as needed based on renal function. - Monitor heart rate: avoid excessive bradycardia, especially in patients with pre‑existing conduction disorders. - Use with caution in asthma or chronic obstructive pulmonary disease: may exacerbate bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension or tachycardia. - Pregnancy and lactation: safety not established; use only if clearly needed and prescribed by a specialist. - Store at below 25°C: keep in original container, protect from light and moisture.

Metopocor can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other beta blockers: risk of severe bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): may cause heart block or profound bradycardia. - Clonidine: abrupt withdrawal while on Metopocor can precipitate severe hypertension. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely): - Non‑selective beta blockers: additive blood pressure‑lowering effect. - NSAIDs: may reduce antihypertensive efficacy. - Antidepressants (SSRIs, SNRIs): potential increase in bradycardia risk.